Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-96.19M
↓ 76% below average
Average (4y)
$-54.76M
Historical baseline
Range
High:$-4.59M
Low:$-96.19M
CAGR
+114.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-96.19M | -49.5% |
| 2023 | $-64.35M | -10.9% |
| 2022 | $-58.04M | -14.7% |
| 2021 | $-50.61M | -1003.1% |
| 2020 | $-4.59M | - |